Participation and Performance Analysis in Children and Adolescents Competing in Time-Limited Ultra-Endurance Running Events.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
03 03 2020
Historique:
received: 08 02 2020
revised: 27 02 2020
accepted: 29 02 2020
entrez: 7 3 2020
pubmed: 7 3 2020
medline: 22 9 2020
Statut: epublish

Résumé

Ultra-endurance running is of increasing popularity in the adult population, mainly due to master runners older than 35 years of age. However, youth runners younger than 19 years of age are also competing in ultra-endurance events, and an increase has been observed in distance-limited events, but no data is available on time-limited ultra-endurance events in this age group. This study investigated participation and performance trends in time-limited ultra-endurance races, including multi-day events, in runners younger than 19 years of age. Between the period 1990 and 2018, the most popular events recorded a total of 214 finishes (from 166 unique finishers (UF)) for 6-hour events, 247 (212 UF) for 12-hour events, and 805 (582 UF) for 24-hour events, respectively. The majority of athletes originated from Europe and North America. Only a minority participated in multi-day events. Overall, speed increased with age, but the overall performance speed decreased across calendar years for 6- and 24-hour events as participation numbers grew. In summary, in youth ultra-endurance runners, differences were observed regarding participation and performance across the different time-limited events, the age of the athletes and their country of origin.

Identifiants

pubmed: 32138338
pii: ijerph17051628
doi: 10.3390/ijerph17051628
pmc: PMC7084740
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Wilderness Environ Med. 2018 Dec;29(4):508-520
pubmed: 30249353
Open Access J Sports Med. 2012 Jul 31;3:73-80
pubmed: 24198590
Extrem Physiol Med. 2013 May 01;2(1):15
pubmed: 23848985
Sports Med Arthrosc Rev. 2019 Mar;27(1):3-7
pubmed: 30601393
Int J Environ Res Public Health. 2019 Jul 04;16(13):
pubmed: 31277399
Open Access J Sports Med. 2018 Mar 01;9:37-45
pubmed: 29535560
Open Access J Sports Med. 2015 Jan 22;6:7-21
pubmed: 25653567
Curr Sports Med Rep. 2005 Jun;4(3):165-70
pubmed: 15907270
Clin J Sport Med. 2011 Sep;21(5):444-6
pubmed: 21860348
Extrem Physiol Med. 2013 Jul 01;2(1):21
pubmed: 23849415
Clinics (Sao Paulo). 2014 Jan;69(1):38-46
pubmed: 24473558
Extrem Physiol Med. 2012 Dec 01;1(1):13
pubmed: 23849138
Open Access J Sports Med. 2013 Jan 11;4:9-18
pubmed: 24379704
Front Physiol. 2018 Jun 01;9:634
pubmed: 29910741
J Sports Med Phys Fitness. 2019 Aug;59(8):1363-1368
pubmed: 31373190
J Sports Sci. 2014;32(4):354-66
pubmed: 24015856
J Strength Cond Res. 2020 May;34(5):1409-1415
pubmed: 32324710
Nutr J. 2013 Jan 15;12:13
pubmed: 23320854
Age (Dordr). 2014;36(5):9715
pubmed: 25280550
Springerplus. 2014 Feb 18;3:97
pubmed: 24616840
Curr Sports Med Rep. 2018 Sep;17(9):282-283
pubmed: 30204629
Age (Dordr). 2012 Aug;34(4):1033-45
pubmed: 21796378
Sports Med. 2015 Oct;45(10):1431-41
pubmed: 26088954
PLoS One. 2018 Jul 11;13(7):e0199701
pubmed: 29995926

Auteurs

Volker Scheer (V)

Ultra Sports Science Foundation, 69130 Pierre-Bénite, France.
Health Science Department, Universidad a Distancia de Madrid (UDIMA), 28400 Collado Villaba, Madrid, Spain.

Stefania Di Gangi (S)

Institute of Primary Care, University of Zurich, 8091 Zürich, Switzerland.

Elias Villiger (E)

Institute of Primary Care, University of Zurich, 8091 Zürich, Switzerland.

Thomas Rosemann (T)

Institute of Primary Care, University of Zurich, 8091 Zürich, Switzerland.

Pantelis T Nikolaidis (PT)

Exercise Physiology Laboratory, 18450 Nikaia, Greece.

Beat Knechtle (B)

Institute of Primary Care, University of Zurich, 8091 Zürich, Switzerland.
Medbase St. Gallen Am Vadianplatz, 9001 St. Gallen, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH